A pharma medical affairs veteran explains why real-world evidence’s biggest constraint isn’t data volume; it’s having enough people to interpret what AI finds.
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Training Program Reduces Placebo Effect By More Than 50% In ePRO Study
Discover how an instruction program directly contributed to significantly lowering the placebo response rate in a phase III migraine CNS study.
-
Email: The Gold Standard For Clinical Trials
Although non-verbal conversations between friends are now primarily conducted through text messages or similar apps, see why email remains the standard mode for businesses and organizations.
-
The Future Of Remote Patient Monitoring In Decentralized Clinical Trials
Remote Patient Monitoring (RPM) is not just an innovation—it's a catalyst redefining how clinical research is conducted in the digital age.
-
Key Efficiencies Driven By A CTMS
Is your clinical trial management system being used to the fullest? Discover the benefits of centralized data management, real-time tracking, automated workflows, and comprehensive reporting.
-
How EDC Software Minimizes Bias In Clinical Trials
Electronic Data Capture (EDC) systems play a crucial role in mitigating bias through automated validation rules, structured workflows, and real-time monitoring.
-
Endpoint Reliability And eCOA Solutions Facilitate CNS Trial Success
A Japan-based pharmaceutical development company utilized Signant's eCOA solutions and knowledge to ensure the reliability of endpoints in their Phase 3 and extended-duration CNS trials.
-
Building A Scalable Oncology Engine In A Dynamic Market
Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly scale the number of oncology trials it could concurrently conduct.
-
Accelerating Site Activation: Examples From Novartis And IQVIA
As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.
-
Unify Your Data With A Centralized eClinical Platform
Despite the challenges associated with large volumes of data, maintaining quality and regulatory compliance, and enhancing patient engagement, the solutions for managing them can be simple and efficient.
-
Aligning Wearable Data Collection Tith Visit Schedules Through EDC Integration
Learn how integrating with an EDC system can streamline monitoring and improve data quality in multi-period trials.
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
RECENT NEWSLETTERS
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives